NeoMed Management is a global venture capital firm from Oslo, Norway that is solely centered around the healthcare industry. Established in 1997, NeoMed has five funds as of 2019. NeoMed puts funding into rising businesses with extraordinary growth possibilities. These companies create inventive and proprietary medicinal products that address considerable market opportunities in the pharmaceutical, medical device and diagnostic areas.
NeoMed invests in all phases of development from start-up to later stage funding. Since starting, NeoMed has effectively funded 30 businesses in Europe, including Scandinavia, Switzerland, Germany and the UK, and in North America. It has offices in Norway and Switzerland. As of 2019, NeoMed is concentrating on NeoMed Innovation IV L.P. and NeoMed Innovation V L.P.
Timeline
Funded Companies
Avitide discovers, develops, manufactures, and supplies custom and catalog biopharmaceutical affinity purification solutions to the biopharmaceutical industry.
A company developing targeted monoclonal antibody immunotherapies for the treatment of infectious diseases
Axonics Modulation Technologies is an Irvine, California-based company.
JenaValve Technology is an Irvine, California-based company.
Kuros Biosurgery is a company in the pharmaceuticals industry.
People
Claudio Nessi
Managing Partner
Dina Chaya
Partner
Erik Amble
Chairman
Pål R. Jensen
Director of Finance
Thomas Goebel
Principal
Vincent Ossipow
Partner
